Quantcast

Latest Mitral valve Stories

2014-10-20 23:05:56

Allegheny General Hospital, part of the Allegheny Health Network, is offering a new, minimally-invasive procedure that enables physicians to repair a damaged mitral valve as the heart continues to beat. The MitraClip system, developed by Abbott Vascular, is designed to treat degenerative mitral regurgitation (MR), a progressive and life-threatening condition in which the heart’s mitral valve leaflets fail to close tightly, allowing blood to flow backward from the heart’s left ventricle...

2014-10-09 08:27:14

NASDAQ: NVCNTSX: NVC VANCOUVER, Oct. 9, 2014 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company's Tiara(TM) transcatheter mitral valve. The TIARA-I Early Feasibility Trial is a multinational, multicenter trial being conducted to...

2014-10-07 08:29:21

Funds to Be Used to Extend Commercial Efforts, Capitalize on Promising Patient Data KIRKLAND, Wash., Oct. 7, 2014 /PRNewswire/ -- Cardiac Dimensions(®) today announced the addition of $8.5 million to its previously announced financing. Arboretum Ventures, a Michigan-based venture capital firm specializing in the healthcare sector, joined an international syndicate of institutional investors from Australia, the U.S. and Canada that includes M.H. Carnegie & Co. and Lumira Capital....

2014-09-29 12:30:22

JENA, Germany, September 29, 2014 /PRNewswire/ -- Occlutech, a leading innovator of products to treat structural heart disease today announced that it has obtained a European CE Mark approval for its dedicated Paravalvular Leak Closure Device, (PLD). The implant is the world's first, specifically designed device indicated for the minimally invasive closure of leaks occurring around artificial aortic and mitral valves. Tor Peters, CEO of the Occlutech Group, commented:...

2014-09-17 08:29:17

Third Multi-Center Study Shows Compelling Results Consistent with Previous Trials; Data Presented at TCT KIRKLAND, Wash., Sept. 17, 2014 /PRNewswire/ -- Cardiac Dimensions(®), Inc. today announced that new long-term outcomes data from the TITAN II clinical trial of its enhanced CARILLON Mitral Contour System showed significant and sustained improvements in mitral regurgitation, functional improvement, quality of life and reverse cardiac remodeling. The long-term safety and efficacy data,...

2014-09-15 12:27:22

Tiara(TM) Transcatheter Mitral Valve program featured in multiple scientific presentations NASDAQ: NVCNTSX: NVC WASHINGTON, DC, Sept. 15, 2014 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) announced today that its Reducer(TM) technology was featured in a "live case" broadcast on Sunday, September 14, 2014 at the 26th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. A Clinical update on the company's Tiara(TM)...

2014-09-10 08:29:45

Harpoon Medical Has Received More than $3M of its Series A Financing to Fund the Initial Clinical Evaluation of the Company's Minimally Invasive Mitral Valve Repair Device STEVENSVILLE, Md., Sept. 10, 2014 /PRNewswire/ -- Harpoon Medical, Inc., a medical device company focused on the development and commercialization of a minimally invasive, beating heart mitral valve repair technology, announced today that the company has successfully raised $3.2M of new capital and expects to...

2014-09-09 12:29:07

STASIS Clinical Study Begins in Europe NEWTOWN, Pa., Sept. 9, 2014 /PRNewswire/ -- Micro Interventional Devices, Inc. (MID) reports the first successful clinical case using its Permaseal Cardiac Access and Closure technology. This new technology simplifies minimally invasive aortic valve replacement procedures. The patient is the first to be enrolled in the Secure Transapical Access and Closure Study (STASIS) being conducted in Europe. The first STASIS case was performed by Dr....

2014-08-12 12:27:43

- Medicare will Provide National Coverage for People with Severe Degenerative Mitral Regurgitation Deemed Too Sick for Surgery ABBOTT PARK, Ill., Aug. 12, 2014 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) recently issued a National Coverage Determination (NCD) that extends coverage for Medicare beneficiaries in the United States to Transcatheter Mitral Valve Repair with Abbott's (NYSE: ABT) MitraClip(® )System. The MitraClip System is a...

2014-08-07 23:11:05

HeartStitch, Inc. receives landmark patent "Suturing Devices and Methods for Suturing an Anatomic Valve" FOUNTAIN VALLEY, CA – (PRWEB) August 07, 2014 -- By: HeartStitch Prof. Anthony Nobles, CEO of HeartStitch HeartStitch, Inc. today announced that it has received another US Patent for its HeartStitch Technology. The patent “Suturing devices and methods for suturing an anatomic valve” is for the HeartStitch MR and AP products that are designed to allow physicians to be...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin